Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-11-09

Clinical Trial Update: Evaluation of Lymphocytic Infiltrate, Dendritic Cells and Cytokines Expression in Psoriatic Lesion and Normal Skin Before and After TNF Alfa Inhibitors Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating lymphocytic infiltration, dendritic cells, and cytokine expression in psoriatic skin before and after TNF inhibitor the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TNF inhibitors

Snippet

Sponsor: University of Padova | Conditions: Moderate to Severe Psoriasis., Absolute Number, Density of Immune Infiltrate and Dendritic Cells and Inflammatory Cytokines Expression Pattern. | Phase 4 | Status: UNKNOWN